# -*- coding: utf-8 -*-
"""
Config v3.0 - Beast Mode (ì•¼ìˆ˜ ëª¨ë“œ)
- í‚¤ì›Œë“œ ì „ëµ ì „ë©´ ê°œí¸: ì„¹í„°ë³„ ì„¸ë¶„í™”
- í•œêµ­ í…Œë§ˆ ëŒ€í­ ê°•í™”
- RIME ì‚¬ë¡€ ë°˜ì˜ (AI/ë¬¼ë¥˜ íš¨ìœ¨í™”)
"""

import os
from dotenv import load_dotenv

load_dotenv()

class Config:
    # API Keys
    TELEGRAM_TOKEN = os.getenv('TELEGRAM_TOKEN')
    TELEGRAM_CHAT_ID = os.getenv('TELEGRAM_CHAT_ID')
    GEMINI_API_KEY = os.getenv('GEMINI_API_KEY')
    FINNHUB_API_KEY = os.getenv('FINNHUB_API_KEY')  # ì„ íƒì‚¬í•­
    ALPHA_VANTAGE_KEY = os.getenv('ALPHA_VANTAGE_KEY')  # ì„ íƒì‚¬í•­
    DART_API_KEY = os.getenv('DART_API_KEY')  # v3.0ì—ì„œëŠ” ì‚¬ìš© ì•ˆ í•¨
    
    @classmethod
    def validate(cls):
        required = ['TELEGRAM_TOKEN', 'TELEGRAM_CHAT_ID', 'GEMINI_API_KEY']
        missing = [k for k in required if not getattr(cls, k)]
        if missing: raise ValueError(f"ëˆ„ë½ëœ API í‚¤: {missing}")
    
    # ğŸ”¥ v3.0 Beast Mode í•„í„° ì„¤ì •
    MIN_MARKET_CAP = 1_000_000  # ì‹œì´ 100ë§Œ ë‹¬ëŸ¬ ì´ìƒ (ì´ˆì†Œí˜•ì£¼ í¬í•¨)
    MAX_MARKET_CAP = 100_000_000_000  # 1000ì–µ ë‹¬ëŸ¬ ë¯¸ë§Œ (ëŒ€í˜•ì£¼/ETF ì œì™¸)
    
    MIN_PRICE = 0.1  # 0.1ë‹¬ëŸ¬ ì´ìƒ (í˜ë‹ˆìŠ¤íƒ í¬í•¨)
    MAX_PRICE = 100.0  # 100ë‹¬ëŸ¬ ì´í•˜
    
    MIN_VOLUME_INCREASE = 500  # ê±°ë˜ëŸ‰ 5ë°° ì´ìƒ (ê¸‰ë“± ì´ˆê¸° í¬ì°©)
    MIN_PRICE_CHANGE = 10.0  # 10% ì´ìƒ ìƒìŠ¹
    MIN_AI_SCORE = 7  # AI ì ìˆ˜ 7ì  ì´ìƒ
    
    # ğŸš¨ POSITIVE_OVERRIDE - ì•…ì¬ í‚¤ì›Œë“œë³´ë‹¤ ë¨¼ì € ì²´í¬ (ìµœìš°ì„  í˜¸ì¬)
    # "ìœ ìƒì¦ì ì² íšŒ" ê°™ì€ ì¼€ì´ìŠ¤: ì•…ì¬ í‚¤ì›Œë“œ(ìœ ìƒì¦ì)ë¥¼ í¬í•¨í•˜ì§€ë§Œ ì‹¤ì œë¡  ê°•í•œ í˜¸ì¬
    POSITIVE_OVERRIDE = [
        # ì•…ì¬ ì² íšŒ/ì·¨ì†Œ â†’ ê°•í•œ í˜¸ì¬
        'ìœ ìƒì¦ì ì² íšŒ', 'ìœ ìƒì¦ì ì·¨ì†Œ', 'ìœ ìƒì¦ì ë°±ì§€í™”',
        'ì „í™˜ì‚¬ì±„ ìƒí™˜', 'ì „í™˜ì‚¬ì±„ ì¡°ê¸°ìƒí™˜', 'ì „í™˜ì‚¬ì±„ ì·¨ì†Œ',
        'ê°ì ì² íšŒ', 'ê°ì ì·¨ì†Œ',
        'ê±°ë˜ì •ì§€ í•´ì œ', 'ìƒì¥íì§€ ì·¨ì†Œ', 'ê´€ë¦¬ì¢…ëª© í•´ì œ',

        # ìì‚¬ì£¼ ê´€ë ¨ (ê¸ì •)
        'ìì‚¬ì£¼ ì†Œê°', 'ìì‚¬ì£¼ ë§¤ì…', 'ìì‚¬ì£¼ ì·¨ë“',

        # ë¬´ìƒì¦ì (ì£¼ì£¼ í™˜ì› â†’ í˜¸ì¬)
        'ë¬´ìƒì¦ì',

        # ì˜ì–´ ì•…ì¬ ì² íšŒ
        'offering withdrawn', 'offering cancelled', 'offering terminated',
        'reverse split cancelled', 'reverse split withdrawn',
    ]

    # ğŸ¯ v3.0 POSITIVE KEYWORDS - ì„¹í„°ë³„ ì„¸ë¶„í™” + í•œêµ­ í…Œë§ˆ + RIME ë°˜ì˜
    POSITIVE_KEYWORDS = [
        # ===================================================================
        # ğŸ§¬ 1. ë°”ì´ì˜¤/í—¬ìŠ¤ì¼€ì–´ (35% - ì—¬ì „íˆ ê°€ì¥ ê°•ë ¥)
        # ===================================================================
        
        # FDA/ê·œì œ ìŠ¹ì¸
        'fda approval', 'fda approved', 'fda clearance', 'fda grants',
        'regulatory approval', 'marketing authorization', 'ce mark',
        'surprise fda nod', 'unexpected approval', 'breakthrough designation',
        
        # ì„ìƒ ì„±ê³µ
        'clinical trial', 'phase 3', 'phase 2', 'phase 1',
        'primary endpoint met', 'statistically significant', 'superior efficacy',
        'positive data', 'positive results', 'met primary endpoint',
        'trial success', 'successful trial', 'pivotal trial',
        'positive top-line', 'positive topline', 'top-line data', 'topline results',
        'proof-of-concept', 'proof of concept', 'poc trial', 'poc study',
        'achieved primary endpoint', 'primary endpoint achieved',
        
        # ì„ìƒ ê²°ê³¼ ì§€í‘œ
        'durable response', 'sustained response', 'complete response', 'partial response',
        'objective response rate', 'orr', 'progression-free survival', 'pfs',
        'overall survival', 'os improvement', 'disease control rate',
        
        # í¬ê·€ì§ˆí™˜/íŠ¹ìˆ˜ ì§€ìœ„
        'orphan drug', 'breakthrough therapy', 'fast track', 'priority review',
        'accelerated approval', 'rare disease', 'first-in-class', 'best-in-class',
        'expanded access', 'compassionate use', 'emergency use authorization', 'eua',
        
        # ë¼ì´ì„¼ì‹±/ì œíœ´
        'licensing agreement', 'license deal', 'global rights', 'exclusive license',
        'milestone payment', 'investigational new drug', 'ind clearance', 'ind application',
        'rolling submission', 'rolling review', 'complete response letter lifted', 'crl lifted',
        'advisory committee', 'adcom positive', 'label expansion', 'indication expansion',
        
        # ì ì‘ì¦
        'moderate-to-severe', 'moderate to severe', 'severe', 'refractory', 'resistant',
        'advanced stage', 'metastatic', 'late-stage', 'late stage',
        
        # ì§ˆí™˜ ì¢…ë¥˜
        'atopic dermatitis', 'psoriasis', 'eczema', 'cancer', 'oncology', 'tumor',
        'alzheimer', 'parkinson', 'diabetes', 'cardiovascular', 'heart failure',
        
        # ëŒ€í˜• ì œì•½ì‚¬ íŒŒíŠ¸ë„ˆì‹­
        'pfizer partnership', 'roche collaboration', 'novartis agreement', 'merck deal',
        'jnj partnership', 'bristol myers', 'gilead', 'abbvie', 'amgen',
        'opt-in rights', 'option agreement', 'co-commercialization', 'royalty agreement',
        
        # ===================================================================
        # ğŸ¤ 2. M&A (25% - ì¦‰ê° ê¸‰ë“±)
        # ===================================================================
        'merger', 'acquisition', 'buyout', 'takeover', 'tender offer', 'all-cash offer',
        'acquired by', 'to be acquired', 'agrees to acquire', 'definitive agreement',
        'merger agreement', 'going private', 'take private',
        
        # QNCX ì‚¬ë¡€ ë°˜ì˜
        'exploring strategic alternatives', 'explore strategic alternatives',
        'strategic alternative', 'reviewing strategic alternatives', 'strategic review',
        'strategic process', 'sale process', 'exploring sale', 'potential sale',
        'explore sale', 'financial advisor', 'exclusive financial advisor',
        'engaged as financial advisor', 'engaged as exclusive', 'lifesci capital',
        'investment bank', 'piper sandler', 'stifel', 'jefferies',
        
        # ===================================================================
        # ğŸ¤– 3. AI/ë°˜ë„ì²´/í…Œí¬ (20% - RIME ì‚¬ë¡€ ë°˜ì˜)
        # ===================================================================
        
        # AI í•µì‹¬ í‚¤ì›Œë“œ
        'artificial intelligence', 'ai partnership', 'ai platform', 'ai technology',
        'machine learning', 'deep learning', 'neural network', 'llm', 'large language model',
        'generative ai', 'ai model', 'ai chip', 'ai accelerator', 'ai inference',
        
        # ì—”ë¹„ë””ì•„/ëŒ€í˜• í…Œí¬ íŒŒíŠ¸ë„ˆì‹­
        'nvidia partnership', 'nvidia isaac', 'nvidia collaboration', 'nvidia platform',
        'microsoft partnership', 'google partnership', 'amazon partnership',
        'openai', 'anthropic', 'meta ai', 'tesla partnership',
        
        # ë°˜ë„ì²´/ì¹©ì…‹
        'semiconductor', 'chip', 'chipset', 'processor', 'gpu', 'asic', 'fpga',
        'advanced packaging', '3nm', '2nm', 'euv', 'high bandwidth memory', 'hbm',
        
        # íš¨ìœ¨ì„±/ì„±ëŠ¥ ê°œì„  (RIME ì‚¬ë¡€)
        'efficiency', 'cost reduction', 'platform launch', 'record high',
        'operational efficiency', 'optimization', 'automation', 'productivity gain',
        'faster processing', 'lower latency', 'improved performance',
        
        # ì†Œí”„íŠ¸ì›¨ì–´/í”Œë«í¼
        'saas', 'platform as a service', 'cloud platform', 'enterprise software',
        'digital transformation', 'api integration', 'subscription model',
        
        # ===================================================================
        # ğŸ”‹ 4. 2ì°¨ì „ì§€/ì—ë„ˆì§€ (15%)
        # ===================================================================
        'battery', 'lithium', 'solid-state battery', 'energy storage', 'ev battery',
        'cathode', 'anode', 'electrolyte', 'battery cell', 'battery pack',
        'gigafactory', 'battery plant', 'capacity expansion',
        'charging', 'fast charging', 'wireless charging',
        'renewable energy', 'solar', 'wind power', 'hydrogen', 'fuel cell',
        'energy efficiency', 'carbon neutral', 'net zero', 'sustainability',
        
        # ===================================================================
        # ğŸ¤– 5. ë¡œë´‡/ìŠ¤ë§ˆíŠ¸íŒ©í† ë¦¬/ë¬¼ë¥˜ (10%)
        # ===================================================================
        'robotics', 'robot', 'automation', 'warehouse automation', 'logistics',
        'supply chain', 'fulfillment', 'autonomous', 'drone delivery',
        'smart factory', 'industry 4.0', 'iot', 'edge computing',
        'predictive maintenance', 'digital twin',
        
        # ===================================================================
        # ğŸš€ 6. ë°©ì‚°/ìš°ì£¼/êµ­ê°€ì•ˆë³´ (10%)
        # ===================================================================
        'defense', 'defense contract', 'military', 'aerospace', 'space',
        'satellite', 'rocket', 'missile', 'drone', 'uav',
        'national security', 'pentagon', 'dod contract', 'navy', 'air force',
        'government contract', 'awarded contract', 'contract win', 'contract award',
        
        # ===================================================================
        # ğŸ”¬ 7. ì–‘ìì»´í“¨íŒ…/ë¯¸ë˜ê¸°ìˆ  (5%)
        # ===================================================================
        'quantum', 'quantum computing', 'quantum chip', 'qubit',
        'superconductor', 'photonics', 'nanotechnology',
        '6g', 'next-generation', 'breakthrough technology',
        
        # ===================================================================
        # ğŸ›ï¸ 8. ì •ë¶€/ì •ì±…/ë³´ì¡°ê¸ˆ (5%)
        # ===================================================================
        'government stake', 'sovereign investment', 'strategic resource',
        'subsidy', 'grant awarded', 'government funding', 'infrastructure bill',
        'chips act', 'inflation reduction act', 'tariff exemption',
        'critical minerals', 'rare earth', 'supply chain security',
        
        # ===================================================================
        # ğŸ’° 9. IPO/SPAC (5%)
        # ===================================================================
        'ipo', 'initial public offering', 'debut', 'spac merger',
        'business combination', 'merger completion', 'de-spac',
        'nasdaq debut', 'nyse debut', 'oversubscribed', 'upsized offering',
        
        # ===================================================================
        # ğŸ“Š 10. ì‹¤ì  ì„œí”„ë¼ì´ì¦ˆ (5%)
        # ===================================================================
        'earnings beat', 'revenue beat', 'guidance raised', 'upgraded guidance',
        'record revenue', 'record earnings', 'record sales', 'blowout quarter',
        'massive beat', 'raised outlook', 'unexpected profit', 'surprise profit',
        
        # ===================================================================
        # ğŸŒ 11. ë¬´ì—­/ì •ì±… (5%)
        # ===================================================================
        'tariff', 'trade policy', 'import ban', 'china ban',
        'alternative supplier', 'supply chain shift', 'reshoring',
        'friend-shoring', 'decoupling',
        
        # ===================================================================
        # ğŸ’ 12. ì•”í˜¸í™”í/ë¸”ë¡ì²´ì¸ (5%)
        # ===================================================================
        'bitcoin', 'ethereum', 'crypto', 'blockchain', 'web3',
        'bitcoin treasury', 'ethereum treasury', 'crypto strategy',
        'nft', 'defi', 'decentralized', 'vitalik buterin',
        
        # ===================================================================
        # ğŸ‡°ğŸ‡· 13. í•œêµ­ í‚¤ì›Œë“œ (20% - ëŒ€í­ ê°•í™”!)
        # ===================================================================

        # ê¸°ë³¸ í˜¸ì¬
        'ìŠ¹ì¸', 'í—ˆê°€', 'ì¸ì¦', 'ìˆ˜ì£¼', 'ê³„ì•½', 'íŠ¹í—ˆ', 'ê°œë°œ', 'ì¶œì‹œ',
        'ì„ìƒ', 'ì„±ê³µ', 'í•©ë³‘', 'ì¸ìˆ˜', 'M&A', 'ì œíœ´', 'í˜‘ë ¥',
        'ì •ë¶€ ê³„ì•½', 'êµ­ë°©', 'ë°©ì‚°', 'ìˆ˜ì¶œ', 'ìˆ˜ì£¼',
        'í‘ìì „í™˜', 'ì‹¤ì ', 'ê°œì„ ', 'ì‹ ì•½', 'ì‹ ì œí’ˆ',

        # ğŸ”¥ í•œêµ­ íŠ¹í™” í…Œë§ˆ (êµ­ì¥ë§Œì˜ íŠ¹ì§•)
        'ê²½ì˜ê¶Œ ë¶„ìŸ', 'ê²½ì˜ê¶Œ ë°©ì–´', 'ìš°í˜¸ì§€ë¶„', 'ì ëŒ€ì  M&A',
        'ë¬´ìƒì¦ì', 'ì•¡ë©´ë¶„í• ', 'ì•¡ë©´ë³‘í•©', 'ì£¼ì‹ë°°ë‹¹',
        'ìì‚¬ì£¼', 'ìì‚¬ì£¼ ì†Œê°', 'ìì‚¬ì£¼ ë§¤ì…',
        'ìœ ìƒì¦ì ì² íšŒ', 'ì „í™˜ì‚¬ì±„ ìƒí™˜',

        # ğŸ”¥ ê¸‰ë“± ì§ê²° ì‹œê·¸ë„
        'ìƒí•œê°€', 'ê¸‰ë“±', 'í’ˆì ˆì£¼', 'ê³µê¸‰ë¶€ì¡±',
        'ì‚¬ìƒ ìµœëŒ€', 'ì‚¬ìƒ ìµœê³ ', 'ì—­ëŒ€ ìµœëŒ€', 'ì—­ëŒ€ ìµœê³ ',
        'ìµœëŒ€ ì‹¤ì ', 'ìµœëŒ€ ìˆ˜ì£¼', 'ìµœëŒ€ ê³„ì•½',
        'ì–´ë‹ì„œí”„ë¼ì´ì¦ˆ', 'ì»¨ì„¼ì„œìŠ¤ ìƒíšŒ', 'ì˜ˆìƒ ìƒíšŒ',
        'í‘ì ì „í™˜', 'ì ì íƒˆì¶œ', 'í„´ì–´ë¼ìš´ë“œ',
        'ëŒ€ê·œëª¨ ìˆ˜ì£¼', 'ê³µê¸‰ ê³„ì•½', 'ë‚©í’ˆ ê³„ì•½', 'ë…ì  ê³µê¸‰',

        # ì •ì¹˜/ì¸ë§¥ í…Œë§ˆ
        'ëŒ€í†µë ¹', 'ì¥ê´€', 'ì—¬ë‹¹', 'ì•¼ë‹¹', 'ì •ì±…', 'íŠ¹ìœ„',
        'êµ­íšŒì˜ì›', 'ì˜ì› ê´€ë ¨ì£¼', 'ì •ì¹˜í…Œë§ˆ',

        # ìƒì¥ ê´€ë ¨
        'ì‹ ê·œìƒì¥', 'ì¬ìƒì¥', 'í•©ë³‘ìƒì¥',
        'ìŠ¤íŒ©', 'ìŠ¤íŒ© í•©ë³‘', 'ìŠ¤íŒ© ëŒ€ìƒ',

        # ì‚°ì—… ìœ¡ì„±/ì§€ì›
        'K-ì¹©ìŠ¤ë²•', 'ë°˜ë„ì²´ ì§€ì›', 'ë°°í„°ë¦¬ ì§€ì›',
        'ì†Œë¶€ì¥', 'ì†Œì¬ë¶€í’ˆì¥ë¹„', 'êµ­ê°€ì „ëµê¸°ìˆ ',

        # ì‹¤ì /ì¬ë¬´
        'ì˜ì—…ì´ìµ ì¦ê°€', 'ë§¤ì¶œ ì¦ê°€', 'ì‹¤ì  ê°œì„ ',

        # í…Œë§ˆ/ì´ìŠˆ
        'ë¶í•œ', 'ë‚¨ë¶ê²½í˜‘', 'ê°œì„±ê³µë‹¨', 'ê¸ˆê°•ì‚°',
        'ì˜¬ë¦¼í”½', 'ì›”ë“œì»µ', 'ì—‘ìŠ¤í¬', 'K-ë°©ì‚°',
        'ì›ìë ¥', 'ì›ì „', 'SMR', 'ì†Œí˜•ëª¨ë“ˆì›ì „',
        '2ì°¨ì „ì§€', 'ì „ê¸°ì°¨', 'ìˆ˜ì†Œì°¨', 'ì¹œí™˜ê²½ì°¨',
    ]
    
    # ğŸš« v3.0 NEGATIVE KEYWORDS - ë…¸ì´ì¦ˆ ëŒ€í­ ê°•í™”
    NEGATIVE_KEYWORDS = [
        # ===================================================================
        # ğŸ’€ 1. ìê¸ˆ ì¡°ë‹¬ (í¬ì„)
        # ===================================================================
        'offering', 'direct offering', 'public offering', 'registered direct offering',
        'shelf offering', 'secondary offering', 'follow-on offering',
        'at-the-market offering', 'atm offering', 'dilution', 'dilutive',
        'share issuance', 'stock issuance', 'warrant exercise',
        'rights offering', 'pipe offering', 'convertible note',
        
        # ===================================================================
        # ğŸª¦ 2. ê¸°ì—… ì¡´ì† ìœ„í—˜
        # ===================================================================
        'bankruptcy', 'chapter 11', 'chapter 7', 'delisting',
        'nasdaq delisting', 'deficiency notice', 'going concern',
        'substantial doubt', 'wind down', 'liquidation', 'restructuring',
        
        # ===================================================================
        # âš–ï¸ 3. ë²•ì /ê·œì œ ë¦¬ìŠ¤í¬
        # ===================================================================
        'investigation', 'sec investigation', 'doj investigation',
        'lawsuit', 'class action', 'securities fraud', 'subpoena',
        'criminal charges', 'recall', 'product recall', 'safety recall',
        'warning letter', 'fda warning', 'crl', 'complete response letter',
        'rejected', 'denial', 'failed to meet', 'clinical hold',
        
        # ===================================================================
        # ğŸ”„ 4. ì£¼ì‹ êµ¬ì¡° ì•…ì¬
        # ===================================================================
        'reverse split', 'reverse stock split', 'stock split',
        'share consolidation',
        
        # ===================================================================
        # â¸ï¸ 5. ê±°ë˜ ì¤‘ë‹¨
        # ===================================================================
        'suspended', 'trading halt', 'halted', 'circuit breaker',
        'volatility halt',
        
        # ===================================================================
        # ğŸ“° 6. ì˜ê²¬/ì „ë§ (ë…¸ì´ì¦ˆ) - ğŸ”¥ ëŒ€í­ ê°•í™”
        # ===================================================================
        'analyst says', 'analyst ratings', 'analyst opinion', 'analyst note',
        'price target', 'upgraded', 'downgraded', 'maintained',
        'opinion', 'preview', 'outlook', 'forecast', 'prediction',
        'summary', 'recap', 'market wrap', 'market update',
        'why it moved', 'what to watch', 'what happened', 'explainer',
        
        # ë…¸ì´ì¦ˆì„± ì»¨í…ì¸ 
        'stock movers', 'pre-market', 'after-hours', 'morning brief',
        'market watch', 'stock alert', 'penny stock', 'meme stock',
        'stock to watch', 'stocks to buy', 'top picks',
        'sponsored', 'advertisement', 'paid promotion',
        
        # ì •ê¸° ì—…ë°ì´íŠ¸
        'investor presentation', 'roadshow', 'quarterly update',
        'monthly update', 'business update', 'corporate update',
        'conference call', 'webcast', 'earnings call',
        'to host', 'will host', 'to present', 'will present',
        
        # SEC ì •ê¸° ë³´ê³ ì„œ (8-KëŠ” ì œì™¸)
        'files 10-k', 'files 10-q', 'files 20-f',
        'annual report', 'quarterly report', 'form 10-k', 'form 10-q',
        
        # ===================================================================
        # ğŸ» 7. ê³µë§¤ë„
        # ===================================================================
        'short seller', 'short report', 'short interest',
        'hindenburg', 'citron', 'muddy waters', 'grizzly research',
        'white diamond', 'bonitas', 'culper',
        
        # ===================================================================
        # ğŸ‡°ğŸ‡· 8. í•œêµ­ ì•…ì¬
        # ===================================================================
        'ë£¨ë¨¸', 'ì¶”ì •', 'ì „ë§', 'ì˜ˆìƒ', 'ê´€ì¸¡',
        'ì ì', 'ì†Œì†¡', 'ìœ ìƒì¦ì', 'ê°ì', 'ìë³¸ì ì‹',
        'ê±°ë˜ì •ì§€', 'ìƒì¥íì§€', 'ê´€ë¦¬ì¢…ëª©', 'íˆ¬ììœ ì˜',
        'ë¶„ì‹íšŒê³„', 'íš¡ë ¹', 'ë°°ì„', 'ê²€ì°°', 'ì¡°ì‚¬',
        'í•˜ë½', 'í­ë½', 'ê¸‰ë½', 'ë§¤ë„',

        # ğŸ”¥ ì¶”ê°€: ì˜¤ë²„í–‰/ë¬¼ëŸ‰ ì•…ì¬
        'ë³´í˜¸ì˜ˆìˆ˜ í•´ì œ', 'ì˜¤ë²„í–‰', 'ë¸”ë¡ë”œ', 'ëŒ€ëŸ‰ ë§¤ë„',
        'ì „í™˜ì²­êµ¬', 'ì „í™˜ê¶Œ í–‰ì‚¬', 'ì›ŒëŸ°íŠ¸ í–‰ì‚¬',

        # ğŸ”¥ ì¶”ê°€: ë…¸ì´ì¦ˆì„± ë‰´ìŠ¤
        'ë¶„ê¸° ì‹¤ì  ë°œí‘œ ì¼ì •', 'ì‹¤ì  ë°œí‘œ ì˜ˆì •', 'ì‹¤ì  ë°œí‘œ ì¼ì •',
        'ì£¼ì£¼ì´íšŒ ì†Œì§‘', 'ì£¼ì£¼ì´íšŒ ì•ˆë‚´', 'ë°°ë‹¹ ê¸°ì¤€ì¼',
        'ê³µì‹œ ì•ˆë‚´', 'ì •ì • ê³µì‹œ',
    ]

    # â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
    # ğŸ†• í‚¤ì›Œë“œ ì ìˆ˜ í…Œì´ë¸” (quick_score AI í˜¸ì¶œ ëŒ€ì²´)
    # ë‰´ìŠ¤ ì œëª©ì—ì„œ ê°€ì¥ ë†’ì€ ì ìˆ˜ì˜ í‚¤ì›Œë“œë¥¼ ì°¾ì•„ ë°˜í™˜
    # ì†ŒìŠ¤ë³„ thresholdì™€ í•¨ê»˜ ì‚¬ìš©: score >= threshold ì‹œ AI ë¶„ì„ ì§„í–‰
    # â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
    KEYWORD_SCORES = {
        # â”€â”€ 10ì : M&A í™•ì • (ì¦‰ê° ê¸‰ë“±) â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
        'acquisition':          10, 'acquired by':          10,
        'to be acquired':       10, 'agrees to acquire':    10,
        'definitive agreement': 10, 'merger agreement':     10,
        'buyout':               10, 'takeover':             10,
        'tender offer':         10, 'all-cash offer':       10,
        'going private':        10, 'take private':         10,
        'merger':               10,
        'ì¸ìˆ˜í•©ì˜':             10, 'ì¸ìˆ˜ì™„ë£Œ':             10,
        'ì¸ìˆ˜ í•©ì˜':            10, 'ì¸ìˆ˜ ì™„ë£Œ':            10,
        'í•©ë³‘ì™„ë£Œ':             10, 'í•©ë³‘ ì™„ë£Œ':            10,
        'ê²½ì˜ê¶Œ ì¸ìˆ˜':          10, 'ìµœëŒ€ì£¼ì£¼ ë³€ê²½':        10,
        'ê³µê°œë§¤ìˆ˜':             10,

        # â”€â”€ 9ì : FDA ìŠ¹ì¸, ì„ìƒ ì„±ê³µ, ëŒ€í˜• ê³„ì•½ í™•ì • â”€â”€â”€â”€â”€â”€â”€â”€â”€
        'fda approval':         9, 'fda approved':          9,
        'fda clearance':        9, 'fda grants':            9,
        'regulatory approval':  9, 'marketing authorization': 9,
        'ce mark':              9,
        'surprise fda nod':     9, 'unexpected approval':   9,
        'breakthrough designation': 9,
        'primary endpoint met': 9, 'met primary endpoint':  9,
        'meets primary endpoint': 9, 'endpoint met':        9,
        'achieved primary endpoint': 9, 'primary endpoint achieved': 9,
        'positive topline':     9, 'positive top-line':     9,
        'top-line data':        9, 'topline results':       9,
        'positive data':        9, 'positive results':      9,
        'trial success':        9, 'successful trial':      9,
        'statistically significant': 9, 'superior efficacy': 9,
        'proof-of-concept':     9, 'proof of concept':      9,
        'poc trial':            9, 'poc study':             9,
        'adcom positive':       9, 'complete response letter lifted': 9,
        'crl lifted':           9,
        'contract win':         9, 'contract award':        9,
        'awarded contract':     9, 'dod contract':          9,
        'ëŒ€ê·œëª¨ ìˆ˜ì£¼':          9, 'ë…ì  ê³µê¸‰':             9,
        'ê²½ì˜ê¶Œ ë¶„ìŸ':          9, 'ì—­ëŒ€ ìµœëŒ€ ê³„ì•½':        9,
        'ìµœëŒ€ ìˆ˜ì£¼':            9, 'ìµœëŒ€ ê³„ì•½':             9,

        # â”€â”€ 8ì : ì „ëµ ëŒ€ì•ˆ, ëŒ€í˜• íŒŒíŠ¸ë„ˆì‹­, ì£¼ì£¼í™˜ì›, ì„ìƒ ì§€ìœ„ â”€
        'phase 3':              8, 'pivotal trial':         8,
        'phase 2':              8,
        'orphan drug':          8, 'breakthrough therapy':  8,
        'fast track':           8, 'priority review':       8,
        'accelerated approval': 8, 'emergency use authorization': 8,
        'eua':                  8,
        'first-in-class':       8, 'best-in-class':         8,
        'expanded access':      8, 'compassionate use':     8,
        'rare disease':         8,
        'durable response':     8, 'sustained response':    8,
        'complete response':    8, 'overall survival':      8,
        'os improvement':       8, 'objective response rate': 8,
        'orr':                  8,
        'pfizer partnership':   8, 'roche collaboration':   8,
        'novartis agreement':   8, 'merck deal':            8,
        'jnj partnership':      8, 'bristol myers':         8,
        'gilead':               8, 'abbvie':                8,
        'amgen':                8,
        'global rights':        8, 'exclusive license':     8,
        'opt-in rights':        8, 'co-commercialization':  8,
        'royalty agreement':    8,
        'exploring strategic alternatives': 8,
        'explore strategic alternatives':   8,
        'strategic review':     8, 'strategic alternative': 8,
        'reviewing strategic alternatives': 8, 'strategic process': 8,
        'sale process':         8, 'exploring sale':        8,
        'potential sale':       8, 'explore sale':          8,
        'financial advisor':    8, 'exclusive financial advisor': 8,
        'engaged as financial advisor': 8, 'engaged as exclusive': 8,
        'investment bank':      8, 'lifesci capital':       8,
        'piper sandler':        8, 'stifel':                8,
        'jefferies':            8,
        'nvidia partnership':   8, 'nvidia':                8,
        'nvidia isaac':         8, 'nvidia collaboration':  8,
        'nvidia platform':      8,
        'microsoft partnership': 8, 'google partnership':   8,
        'amazon partnership':   8, 'openai':                8,
        'anthropic':            8, 'meta ai':               8,
        'tesla partnership':    8,
        'major contract':       8, 'government contract':   8,
        'defense contract':     8, 'dod contract':          8,
        'pentagon':             8,
        'ë¬´ìƒì¦ì':             8, 'ìì‚¬ì£¼ ì†Œê°':           8,
        'í‘ìì „í™˜':             8, 'í‘ì ì „í™˜':             8,
        'ìƒí•œê°€':               8, 'ì‚¬ìƒ ìµœëŒ€':             8,
        'ì‚¬ìƒ ìµœê³ ':            8, 'ì—­ëŒ€ ìµœëŒ€':             8,
        'ì—­ëŒ€ ìµœê³ ':            8, 'ì–´ë‹ì„œí”„ë¼ì´ì¦ˆ':        8,

        # â”€â”€ 7ì : íŒŒíŠ¸ë„ˆì‹­, ì¤‘í˜•ê³„ì•½, ì„ìƒ ë°ì´í„°, ì‹¤ì  ì„œí”„ë¼ì´ì¦ˆ â”€
        'partnership':          7, 'collaboration':         7,
        'license deal':         7, 'licensing agreement':   7,
        'milestone payment':    7,
        'investigational new drug': 7, 'ind clearance':     7,
        'ind application':      7, 'rolling submission':    7,
        'rolling review':       7, 'advisory committee':    7,
        'label expansion':      7, 'indication expansion':  7,
        'partial response':     7, 'progression-free survival': 7,
        'pfs':                  7, 'disease control rate':  7,
        'phase 1':              7, 'clinical trial':        7,
        'option agreement':     7,
        'ai partnership':       7, 'ai platform':           7,
        'machine learning':     7, 'deep learning':         7,
        'neural network':       7, 'llm':                   7,
        'large language model': 7, 'generative ai':         7,
        'ai model':             7, 'ai chip':               7,
        'ai accelerator':       7, 'ai inference':          7,
        'ai technology':        7,
        'chipset':              7, 'processor':             7,
        'gpu':                  7, 'asic':                  7,
        'fpga':                 7, 'advanced packaging':    7,
        '3nm':                  7, '2nm':                   7,
        'euv':                  7, 'high bandwidth memory': 7,
        'hbm':                  7, 'semiconductor':         7,
        'chip':                 7,
        'raises':               7, 'private placement':     7,
        'grant awarded':        7, 'government funding':    7,
        'subsidy':              7, 'infrastructure bill':   7,
        'chips act':            7, 'inflation reduction act': 7,
        'government stake':     7, 'sovereign investment':  7,
        'strategic resource':   7, 'tariff exemption':      7,
        'critical minerals':    7, 'rare earth':            7,
        'supply chain security': 7,
        'defense':              7, 'military':              7,
        'aerospace':            7, 'space':                 7,
        'satellite':            7, 'rocket':                7,
        'missile':              7, 'uav':                   7,
        'national security':    7, 'navy':                  7,
        'air force':            7,
        'spac merger':          7, 'business combination':  7,
        'merger completion':    7, 'de-spac':               7,
        'nasdaq debut':         7, 'nyse debut':            7,
        'oversubscribed':       7, 'upsized offering':      7,
        'earnings beat':        7, 'revenue beat':          7,
        'guidance raised':      7, 'upgraded guidance':     7,
        'record revenue':       7, 'record earnings':       7,
        'record sales':         7, 'blowout quarter':       7,
        'massive beat':         7, 'raised outlook':        7,
        'unexpected profit':    7, 'surprise profit':       7,
        'record high':          7,
        'solid-state battery':  7, 'ev battery':            7,
        'gigafactory':          7, 'battery plant':         7,
        'capacity expansion':   7, 'energy storage':        7,
        'quantum computing':    7, 'quantum chip':          7,
        'quantum':              7, 'qubit':                 7,
        'superconductor':       7, 'photonics':             7,
        'nanotechnology':       7, 'breakthrough technology': 7,
        'ìˆ˜ì£¼':                 7, 'ê³„ì•½':                  7,
        'í•©ì˜':                 7, 'íŠ¹í—ˆ':                  7,
        'ì„ìƒ ì„±ê³µ':            7, 'í‘ì':                  7,
        'ê¸‰ë“±':                 7, 'ì»¨ì„¼ì„œìŠ¤ ìƒíšŒ':         7,
        'ì˜ˆìƒ ìƒíšŒ':            7, 'í„´ì–´ë¼ìš´ë“œ':            7,
        'ìµœëŒ€ ì‹¤ì ':            7,
        'ì¸ìˆ˜':                 7, 'í•©ë³‘':                  7,
        'ì œíœ´':                 7, 'í˜‘ë ¥':                  7,
        'ìˆ˜ì¶œ':                 7, 'ì •ë¶€ ê³„ì•½':             7,
        'êµ­ë°©':                 7, 'ë°©ì‚°':                  7,
        'K-ë°©ì‚°':               7,
        'ì‹ ì•½':                 7, 'ì‹ ì œí’ˆ':                7,
        'ì„ìƒ':                 7, 'ì„±ê³µ':                  7,
        'í—ˆê°€':                 7, 'ìŠ¹ì¸':                  7,
        'ì¸ì¦':                 7,
        'ê²½ì˜ê¶Œ ë°©ì–´':          7, 'ìš°í˜¸ì§€ë¶„':              7,
        'ì ëŒ€ì  M&A':           7, 'M&A':                   7,
        'í’ˆì ˆì£¼':               7, 'ê³µê¸‰ë¶€ì¡±':              7,
        'ê³µê¸‰ ê³„ì•½':            7, 'ë‚©í’ˆ ê³„ì•½':             7,
        'ì˜ì—…ì´ìµ ì¦ê°€':        7, 'ë§¤ì¶œ ì¦ê°€':             7,
        'ì‹¤ì  ê°œì„ ':            7, 'ì‹¤ì ':                  7,
        'ê°œì„ ':                 7,
        'SMR':                  7, 'ì†Œí˜•ëª¨ë“ˆì›ì „':          7,
        'ì›ìë ¥':               7, 'ì›ì „':                  7,

        # â”€â”€ 6ì : ì œí’ˆ ì¶œì‹œ, AI ëŸ°ì¹­, í…Œë§ˆì£¼, ì—ë„ˆì§€ (ì‹ ë¢° ì†ŒìŠ¤ì—ì„œ í†µê³¼) â”€
        'launches':             6, 'launch':                6,
        'platform launch':      6, 'agentic ai':            6,
        'artificial intelligence': 6, 'api integration':   6,
        'api launch':           6, 'saas':                  6,
        'platform as a service': 6, 'cloud platform':       6,
        'enterprise software':  6, 'digital transformation': 6,
        'subscription model':   6,
        'efficiency':           6, 'cost reduction':        6,
        'operational efficiency': 6, 'optimization':        6,
        'automation':           6, 'productivity gain':     6,
        'faster processing':    6, 'lower latency':         6,
        'improved performance': 6,
        'robotics':             6, 'robot':                 6,
        'warehouse automation': 6, 'logistics':             6,
        'supply chain':         6, 'fulfillment':           6,
        'autonomous':           6, 'drone delivery':        6,
        'smart factory':        6, 'industry 4.0':          6,
        'iot':                  6, 'edge computing':        6,
        'predictive maintenance': 6, 'digital twin':        6,
        'drone':                6,
        'battery':              6, 'lithium':               6,
        'cathode':              6, 'anode':                 6,
        'electrolyte':          6, 'battery cell':          6,
        'battery pack':         6,
        'charging':             6, 'fast charging':         6,
        'wireless charging':    6,
        'renewable energy':     6, 'solar':                 6,
        'wind power':           6, 'hydrogen':              6,
        'fuel cell':            6, 'energy efficiency':     6,
        'carbon neutral':       6, 'net zero':              6,
        'sustainability':       6,
        '6g':                   6, 'next-generation':       6,
        'tariff':               6, 'trade policy':          6,
        'import ban':           6, 'china ban':             6,
        'alternative supplier': 6, 'supply chain shift':    6,
        'reshoring':            6, 'friend-shoring':        6,
        'decoupling':           6,
        'bitcoin':              6, 'ethereum':              6,
        'crypto':               6, 'blockchain':            6,
        'web3':                 6, 'bitcoin treasury':      6,
        'ethereum treasury':    6, 'crypto strategy':       6,
        'nft':                  6, 'defi':                  6,
        'decentralized':        6, 'vitalik buterin':       6,
        'ipo':                  6, 'initial public offering': 6,
        'debut':                6, 'spac':                  6,
        'ì‹ ê·œìƒì¥':             6, 'ì¬ìƒì¥':                6,
        'í•©ë³‘ìƒì¥':             6, 'ìŠ¤íŒ© í•©ë³‘':             6,
        'ìŠ¤íŒ©':                 6, 'ìŠ¤íŒ© ëŒ€ìƒ':             6,
        '2ì°¨ì „ì§€':              6, 'ì „ê¸°ì°¨':                6,
        'ìˆ˜ì†Œì°¨':               6, 'ì¹œí™˜ê²½ì°¨':              6,
        'ê°œë°œ':                 6, 'ì¶œì‹œ':                  6,
        'ìì‚¬ì£¼':               6, 'ì•¡ë©´ë¶„í• ':              6,
        'ì•¡ë©´ë³‘í•©':             6, 'ì£¼ì‹ë°°ë‹¹':              6,
        'ì ì íƒˆì¶œ':            6,
        'K-ì¹©ìŠ¤ë²•':             6, 'ë°˜ë„ì²´ ì§€ì›':           6,
        'ë°°í„°ë¦¬ ì§€ì›':          6, 'ì†Œë¶€ì¥':                6,
        'ì†Œì¬ë¶€í’ˆì¥ë¹„':         6, 'êµ­ê°€ì „ëµê¸°ìˆ ':          6,

        # â”€â”€ 5ì : í…Œë§ˆ/ì •ì¹˜/ì´ìŠˆ (ë‚®ì€ threshold ì†ŒìŠ¤ì—ì„œë§Œ í†µê³¼) â”€
        'moderate-to-severe':   5, 'moderate to severe':   5,
        'severe':               5, 'refractory':           5,
        'resistant':            5, 'advanced stage':       5,
        'metastatic':           5, 'late-stage':           5,
        'late stage':           5,
        'atopic dermatitis':    5, 'psoriasis':            5,
        'eczema':               5, 'cancer':               5,
        'oncology':             5, 'tumor':                5,
        'alzheimer':            5, 'parkinson':            5,
        'diabetes':             5, 'cardiovascular':       5,
        'heart failure':        5,
        'ëŒ€í†µë ¹':               5, 'ì¥ê´€':                 5,
        'ì—¬ë‹¹':                 5, 'ì•¼ë‹¹':                 5,
        'ì •ì±…':                 5, 'íŠ¹ìœ„':                 5,
        'êµ­íšŒì˜ì›':             5, 'ì˜ì› ê´€ë ¨ì£¼':           5,
        'ì •ì¹˜í…Œë§ˆ':             5,
        'ë¶í•œ':                 5, 'ë‚¨ë¶ê²½í˜‘':             5,
        'ê°œì„±ê³µë‹¨':             5, 'ê¸ˆê°•ì‚°':               5,
        'ì˜¬ë¦¼í”½':               5, 'ì›”ë“œì»µ':               5,
        'ì—‘ìŠ¤í¬':               5,
    }

    # â”€â”€ ì†ŒìŠ¤ë³„ threshold (ë‚®ì„ìˆ˜ë¡ ë” ë§ì€ ë‰´ìŠ¤ í†µê³¼) â”€â”€â”€â”€â”€â”€â”€â”€
    # ê³µì‹ ë³´ë„ìë£Œ ë°°í¬ ì„œë¹„ìŠ¤ (ê¸°ì—…ì´ ì§ì ‘ ì˜¬ë¦¼ â†’ ë£¨ë¨¸ ì—†ìŒ) â†’ 6ì 
    # í¸ì§‘ ê¸°ì‚¬ í˜¼ì¬ ì†ŒìŠ¤ â†’ 7ì 
    # ì†ë³´/ë£¨ë¨¸ ê°€ëŠ¥ì„± ì†ŒìŠ¤ â†’ 8ì 
    SOURCE_THRESHOLD = {
        'PR Newswire':      6.0,
        'GlobeNewswire':    6.0,
        'Business Wire':    6.0,
        'SEC 8-K':          6.0,
        'Benzinga':         7.0,
        'ë§¤ì¼ê²½ì œ':         7.0,
        'í•œêµ­ê²½ì œ':         7.0,
        'ë„¤ì´ë²„ ì¦ê¶Œ ì†ë³´': 8.0,
    }

    @classmethod
    def keyword_score(cls, title: str) -> float:
        """
        ğŸ†• AI ì—†ì´ ìˆœìˆ˜ í‚¤ì›Œë“œë¡œ ë‰´ìŠ¤ ê¸´ê¸‰ë„ ì ìˆ˜ ê³„ì‚° (0~10)
        ìš°ì„ ìˆœìœ„:
          1. POSITIVE_OVERRIDE â†’ 9ì  ê³ ì • (ì•…ì¬ ì² íšŒ ì¼€ì´ìŠ¤)
          2. KEYWORD_SCORES    â†’ í•´ë‹¹ í‚¤ì›Œë“œì˜ ì •ì˜ëœ ì ìˆ˜
          3. POSITIVE_KEYWORDS â†’ 5ì  (ê¸°ë³¸ í˜¸ì¬, í‚¤ì›Œë“œ ì ìˆ˜ ë¯¸ì •ì˜)
          4. ì—†ìŒ              â†’ 0ì 
        """
        title_lower = title.lower()

        # 1ìˆœìœ„: POSITIVE_OVERRIDE (ì•…ì¬ ì² íšŒ â†’ í•­ìƒ ê°•í•œ í˜¸ì¬)
        for kw in cls.POSITIVE_OVERRIDE:
            if kw.lower() in title_lower:
                return 9.0

        # 2ìˆœìœ„: KEYWORD_SCORES (ê¸´ í‚¤ì›Œë“œ ë¨¼ì € ì²´í¬ â†’ ì •í™•ë„ í–¥ìƒ)
        best_score = 0.0
        for kw, score in sorted(cls.KEYWORD_SCORES.items(),
                                 key=lambda x: len(x[0]), reverse=True):
            if kw.lower() in title_lower and score > best_score:
                best_score = float(score)

        if best_score > 0:
            return best_score

        # 3ìˆœìœ„: ê¸°ë³¸ POSITIVE_KEYWORDS (ì ìˆ˜ ì •ì˜ ì•ˆ ëœ í‚¤ì›Œë“œ)
        for kw in cls.POSITIVE_KEYWORDS:
            if kw.lower() in title_lower:
                return 5.0

        return 0.0

    # Reddit ì„¤ì • (ì„ íƒì‚¬í•­)
    REDDIT_MIN_MENTIONS = 10
    REDDIT_SUBREDDITS = ['wallstreetbets', 'stocks', 'investing', 'pennystocks']
    
    # ğŸ”¥ v3.0 Beast Mode ì„¤ì •
    BEAST_MODE = True  # ì•¼ìˆ˜ ëª¨ë“œ í™œì„±í™”
    ENABLE_MICRO_CAPS = True  # ì´ˆì†Œí˜•ì£¼ í¬í•¨
    ENABLE_PENNY_STOCKS = True  # í˜ë‹ˆìŠ¤íƒ í¬í•¨
    AGGRESSIVE_SCANNING = True  # ê³µê²©ì  ìŠ¤ìºë‹

try:
    Config.validate()
except ValueError as e:
    print(f"âš ï¸ ì„¤ì • ì˜¤ë¥˜: {e}")
